Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brown adipose tissue
- 9 October 2020
- journal article
- research article
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 37 (3) , 441-460
Abstract
Myopathy is the major adverse effect of statins. However, the underlying mechanism of statin-induced skeletal muscle atrophy, one of statin-induced myopathy, remains to be elucidated. Myostatin is a negative regulator of skeletal muscle mass and functions. Whether myostatin is involved in statin-induced skeletal muscle atrophy remains unknown. In this study, we uncovered that simvastatin administration increased serum myostatin levels in mice. Inhibition of myostatin with follistatin, an antagonist of myostatin, improved simvastatin-induced skeletal muscle atrophy. Simvastatin induced myostatin expression not only in skeletal muscle but also in brown adipose tissue (BAT). Mechanistically, simvastatin inhibited the phosphorylation of forkhead box protein O1 (FOXO1) in C2C12 myotubes, promoting the nuclear translocation of FOXO1 and thereby stimulating the transcription of myostatin. In differentiated brown adipocytes, simvastatin promoted myostatin expression mainly by inhibiting the expression of interferon regulatory factor 4 (IRF4). Moreover, the stimulative effect of simvastatin on myostatin expression was blunted by geranylgeranyl diphosphate (GGPP) supplementation in both myotubes and brown adipocytes, suggesting that GGPP depletion was attributed to simvastatin-induced myostatin expression. Besides, the capacities of statins on stimulating myostatin expression were positively correlated with the lipophilicity of statins. Our findings provide new insights into statin-induced skeletal muscle atrophy. Graphical headlights 1. Simvastatin induces skeletal muscle atrophy via increasing serum myostatin levels in mice; 2. Simvastatin promotes myostatin expression in both skeletal muscle and brown adipose tissue through inhibiting GGPP production; 3. The stimulating effect of statins on myostatin expression is positively correlated with the lipophilicity of statins.Keywords
Funding Information
- National Key R&D Program of China (2019YFC1711000)
- National Natural Science Foundation of China (81722048)
This publication has 62 references indexed in Scilit:
- Oxidative stress as a possible mechanism of statin-induced myopathyInflammopharmacology, 2018
- IGF-1 prevents simvastatin-induced myotoxicity in C2C12 myotubesArchives of Toxicology, 2016
- Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial FibrillationCirculation, 2016
- Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in miceNature Medicine, 2015
- The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicityBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2015
- Simvastatin induces mitochondrial dysfunction and increased atrogin-1 expression in H9c2 cardiomyocytes and mice in vivoArchives of Toxicology, 2014
- Myostatin Regulates Energy Homeostasis in the Heart and Prevents Heart FailureCirculation Research, 2014
- Statin‐induced muscle damage and atrogin‐1 induction is the result of a geranylgeranylation defectThe FASEB Journal, 2009
- Comparative functional analysis of the cow and mouse myostatin genes reveals novel regulatory elements in their upstream promoter regionsComparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 2008
- Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factorsAmerican Journal of Physiology-Cell Physiology, 2007